#USA #New York #Kuehn Law #TGI #NVRO

Kuehn Law's Call to Shareholders

In an important announcement, Kuehn Law, PLLC, a respected law firm specializing in shareholder litigation, is actively investigating potential claims associated with several proposed mergers involving Nevro Corp. (NYSE NVRO), ACELYRIN, INC. (NASDAQ SLRN), Triumph Group, Inc. (NYSE TGI), and Portman Ridge Finance Corporation (NASDAQ PTMN). This investigation raises critical questions for shareholders who need to stay informed and take swift action to protect their interests.

Overview of Mergers Under Investigation

1. Nevro Corp. (NVRO) has confirmed a tri-party agreement with Globus Medical. Shareholders are set to receive $5.85 per share. Both companies' boards unanimously approved this merger, which is targeted for completion in late Q2 2025, pending shareholder and regulatory approval. This proposed acquisition presents not only a financial opportunity but also a situation where shareholders must ensure that the deal maximizes their value.

2. ACELYRIN, INC. (SLRN) is preparing for its acquisition by Alumis Inc. This deal proposes a conversion of shares whereby holders of Acelyrin’s common stock will receive 0.4274 shares of Alumis’s common stock for each share they own. Once finalized, this merger indicates that Alumis stockholders would own about 55% of the new entity, leaving Acelyrin stockholders with the remainder. It is crucial for shareholders to ensure this stock swap is executed fairly and transparently.

3. Triumph Group, Inc. (TGI) has authorized a purchase agreement with Warburg Pincus and Berkshire Partners to sell shares for $26.00 each in cash. Should the transaction be completed, Triumph will transition into a privately-held company. This shift entails significant changes for shareholders, thus Kuehn Law is urging them to assess how this shift may impact their investment security.

4. Portman Ridge Finance Corporation (PTMN) plans to be acquired by Logan Ridge Finance Corporation. Under this arrangement, Portman Ridge finance will continue to trade on Nasdaq under its existing symbol, PTMN, but shareholders must ascertain that their stakes remain protected throughout this transition.

Importance of Shareholder Participation

Kuehn Law emphasizes that the active participation of shareholders plays a crucial role in maintaining market integrity and ensuring fairness in financial dealings. Their campaign titled "Your Investment. Your Voice. Your Future.™" encourages those holding shares in the aforementioned companies to examine their rights rigorously. By engaging in this process, shareholders not only defend their personal investments but also contribute to the overall integrity of the financial markets, fostering a just environment for all investors.

Next Steps for Concerned Shareholders

Shareholders who feel that their interests may be compromised during these merger proceedings are encouraged to reach out to Kuehn Law. The firm is committed to advocating for shareholder rights without imposing any costs for representation. Concerned parties can contact them via email at [email protected] or dial 833-672-0814. Given the time-sensitive nature of legal rights, prompt action is urged.

In summary, Kuehn Law’s investigation underscores the critical nature of shareholder advocacy in the face of corporate mergers. Shareholders must remain vigilant and proactive to safeguard their interests effectively. For more information on merger litigation and how Kuehn Law can assist, potential clients can visit their official website.

Conclusion

As Kuehn Law continues to represent shareholders, it remains a strong ally in the quest for justice and equity in the shifting landscape of corporate mergers and acquisitions. Stay engaged, informed, and proactive in defending your financial future.